ask="N/A"
ask_size="N/A"
average_daily_volume="51763"
bid="12.150"
bid_size="100"
book_value="3.166"
change="-0.035"
change_from_200_day_moving_average="2.407"
change_from_50_day_moving_average="0.576"
change_from_52_week_high="-0.665"
change_From_52_week_low="9.205"
change_in_percent="-0.165%"
close="21.125"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.714"
ebitda="-68.70M"
eps_estimate_current_year="-2.370"
eps_estimate_next_quarter="-0.580"
eps_estimate_next_year="-2.100"
ex_dividend_date="N/A"
float_shares="10188000"
high="21.470"
high_52_weeks="21.790"
last_trade_date="1/30/2017"
last_trade_price="21.125"
last_trade_size="100"
last_trade_time="4:00pm"
low="19.951"
low_52_weeks="11.920"
market_capitalization="532.54M"
moving_average_200_day="18.718"
moving_average_50_day="20.549"
name="Ascendis Pharma A/S"
notes="N/A"
one_year_target_price="29.670"
open="20.870"
pe_ratio="N/A"
peg_ratio="-0.370"
percent_change_from_200_day_moving_average="+12.857%"
percent_change_from_50_day_moving_average="+2.804%"
percent_change_from_52_week_high="-3.052%"
percent_change_from_52_week_low="+77.223%"
previous_close="21.160"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.684"
price_per_sales="89.753"
revenue="5.94M"
shares_outstanding="25209000"
short_ratio="8.240"
stock_exchange="NMS"
symbol="ASND"
volume="18889"
weeks_range_52="11.920 - 21.790"
